Impact of <i>Opuntia ficus-indica</i> Juice and Empagliflozin on Glycemic Control in Rats
2024
Sondos M. Alqudah | Mohammad Hailat | Zainab Zakaraya | Alaa Azeez Abu Dayah | Mohammad Abu Assab | Samia M. Alarman | Riad M. Awad | Mohammed F. Hamad | Laura Grațiela Vicaș | Wael Abu Dayyih
Diabetes mellitus (DM) is a major global health concern characterized by high blood glucose levels. This study investigates the effects of <i>Opuntia ficus-indica</i> (cactus) juice and empagliflozin, both alone and in combination, on glycated hemoglobin (HbA1c) levels in healthy and streptozotocin-induced diabetic rats. Eighty Wistar albino male rats were divided into eight groups, with four groups being diabetic. Treatment options included cactus juice, empagliflozin, or both. HbA1c levels were measured at baseline and 100 days later using ELISA. In diabetic and non-diabetic rats treated with cactus juice or empagliflozin, HbA1c levels were significantly reduced, but diabetic rats had significantly lower HbA1c values than non-diabetic rats. The combined treatment provided no additional benefits over individual therapies. These findings indicate that cactus juice and empagliflozin effectively lower HbA1c levels, making their use a promising complementary approach to diabetes management. However, the combined treatment of <i>Opuntia ficus-indica</i> juice and empagliflozin did not yield additional reductions in HbA1c levels compared to individual treatments, with no significant synergistic effects observed throughout the study period. More research is needed to better understand the clinical applications and mechanisms in humans.
显示更多 [+] 显示较少 [-]